Bellerophon Therapeutics, Inc. Gains 37.21%
Wed, Jan 10, 2024 at 07:33 PM
Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) jumped higher at $0.06, representing a gain of 37.2%. On Wed, Jan 10, 2024, BLPH:NASDAQ hit a New 2-Week High of $0.06. From Wed, Dec 27, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days
About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.
Top 10 Gainers:
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 300%
- Nauticus Robotics Inc. (KITT:NASDAQ), 78.65%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 61.19%
- Vinco Ventures Inc. (BBIG:NASDAQ), 57.14%
- NewAmsterdam Pharma Company N.V. (NAMS:NASDAQ), 39.85%
- Sana Biotechnology, Inc. (SANA:NASDAQ), 39.28%
- Top KingWin Ltd (TCJH:NASDAQ), 38.55%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 37.21%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 36.53%
- Roma Green Finance Limited (ROMA:NASDAQ), 36.21%